Navigation Links
Dabur India Q4 Profit Surges 31%

The Board of Directors of Dabur India Ltd (DIL) met here today to consider the audited financial results of the company for the quarter and the full year ending March 31, 2007.

Dabur India Limited is one of Indias leading FMCG Companies. Building on a legacy of quality and experience for over 120 years, Dabur today is Indias most trusted name and the worlds largest Ayurvedic and Natural Health Care Company. The largest Indian Personal Care and Health Care Company, Dabur India is also a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products.

Riding on strong growth across its core categories, Dabur India Ltd recorded a 30.8 per cent increase in net profit during the fourth quarter of 2006-07 to Rs 65.70 crore as against Rs 50.22 crore in the corresponding quarter of the previous fiscal. Its turnover for the quarter stood at Rs 444.76 crore, up 33.7 per cent over Rs 332.69 crore earned a year earlier.

For the full year ended March 31, 2007, Dabur India net profit surged by 33.3 per cent to Rs 252.08 crore from Rs 189.08 crore in 2005-06. Its turnover for the fiscal also marked a 29.8 per cent growth at Rs 1778.02 crore from Rs 1369.68 crore a year earlier.

Dabur India has recorded strong growth in key categories like hair and oral care, health supplements, foods and home care. The Foods Business recorded a strong growth of 28 per cent during the year, while the international business posted a growth of 29.3 per cent, driven by our business in Egypt, Pakistan and the GCC region, Dabur India Ltd Chief Executive Officer Mr. Sunil Duggal said

In the Oral Care category, toothpaste sales led by Babool and Dabur Red reported a 28 per cent growth year-on-year. Vatika led the growth in the Shampoo category, which posted a 31 per cent surge in sales during the year. With this, Dabur has emerged as the fastest growing player in the highly competitive Shampoo and Oral Care categories .

The Health Supplements category continued its strong performance ending the year with a growth of 19.5 per cent. Dabur India's Home Care portfolio sales also surged 35.1 per cent, with Odonil growing by 28.2 per cent and Odomos by 71 per cent.

The Board of Directors has recommended that the interim dividend announced earlier be considered as the final dividend for the year. We have maintained out pay-out policy in 2006-07 and have disbursed a total dividend of 213% during the year on pre-bonus capital, Dabur India chairman Mr. V C Burman said.

Dabur India (Consolidated)

Dabur India Ltd (Consolidated) recorded a 53.9 per cent surge in net profit during the fourth quarter of the 2006-07 financial year. Its net profit for the quarter stood at Rs 76.91 crore, up from Rs 49.96 crore in the same period last year. Turnover for the quarter also marked a 20.1 per cent increase to Rs 576.49 crore from Rs 479.93 crore in the corresponding quarter of the previous fiscal.

For the financial year ended March 31, 2007, consolidated net profit soared 32.2 per cent to Rs 283.04 crore as against Rs 214.18 crore in the previous fiscal. Consolidated turnover for the full year stood at Rs 2233.72 crore, a jump of 17.6 per cent over Rs 1899.57 in 2005-06.

Overseas sales also recorded significant gains, growing by 29.3 per cent in 2006-07 with strong performances across most focus markets. We have built strong capabilities to tap emerging opportunities. Sales in the GCC region have increased by 29 per cent, while Dabur Egypt reported a 59 per cent growth. Sales in Pakistan touched Rs 20 crore, and exports to new markets in the Middle East and North Africa have commenced, said Dabur India Ltd Group Director Mr. P D Narang.


'"/>




Related medicine news :

1. Dabur Research to set up Drug Discovery Center in Oman
2. Is Diabetes the Leading Cause of Kidney Failure in India
3. AIDS Disaster in India is Imminent
4. Indian Prime Minister has successful Knee Replacement Surgery
5. International community warns India on HIV situation
6. India takes on foot-and-mouth disease by vaccinating animals
7. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
8. India to benefit from pharma companies move
9. Healthcare sector is now a multi billion-dollar industry in India
10. The World Bank funds private Hospital in India
11. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: